|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
283:11340-11347
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
|
|
S.Runge,
H.Thøgersen,
K.Madsen,
J.Lau,
R.Rudolph.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The glucagon-like peptide-1 receptor (GLP-1R) belongs to Family B1 of the
seven-transmembrane G protein-coupled receptors, and its natural agonist ligand
is the peptide hormone glucagon-like peptide-1 (GLP-1). GLP-1 is involved in
glucose homeostasis, and activation of GLP-1R in the plasma membrane of
pancreatic beta-cells potentiates glucose-dependent insulin secretion. The
N-terminal extracellular domain (nGLP-1R) is an important ligand binding domain
that binds GLP-1 and the homologous peptide Exendin-4 with differential
affinity. Exendin-4 has a C-terminal extension of nine amino acid residues known
as the "Trp cage", which is absent in GLP-1. The Trp cage was believed to
interact with nGLP-1R and thereby explain the superior affinity of Exendin-4.
However, the molecular details that govern ligand binding and specificity of
nGLP-1R remain undefined. Here we report the crystal structure of human nGLP-1R
in complex with the antagonist Exendin-4(9-39) solved by the multiwavelength
anomalous dispersion method to 2.2A resolution. The structure reveals that
Exendin-4(9-39) is an amphipathic alpha-helix forming both hydrophobic and
hydrophilic interactions with nGLP-1R. The Trp cage of Exendin-4 is not involved
in binding to nGLP-1R. The hydrophobic binding site of nGLP-1R is defined by
discontinuous segments including primarily a well defined alpha-helix in the N
terminus of nGLP-1R and a loop between two antiparallel beta-strands. The
structure provides for the first time detailed molecular insight into ligand
binding of the human GLP-1 receptor, an established target for treatment of type
2 diabetes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIGURE 3. Superposition of the solution NMR structure of
Ex4 in TFE (Protein Data Bank code 1JRJ) and the receptor-bound
crystal structure of Ex4(9–39). The surface of nGLP-1R is
illustrated in gray, highlighting the hydrophobic binding cavity
in magenta. The secondary structure of receptor-bound
Ex4(9–39) is illustrated in blue. The side chains of Glu^15*,
Val^19*, Phe^22*, Ile^23*, Trp^25*, Leu^26*, Pro^31*, and
Ser^32*, of receptor-bound Ex4(9–39) and Ex4 in solution are
shown in blue and yellow sticks, respectively.
|
 |
Figure 4.
FIGURE 4. Superposition of ligand-bound nPAC1, nCRF-R2B,
nGIPR, and nGLP-1R. The conserved core structures of the
Nt-domains were aligned by superposition of the ligand-bound
structures using PyMOL. A surface representation of nGLP-1R is
shown in gray, and the ligands are illustrated by ribbon
diagrams, Ex4(9–39) in blue, GIP(1–42) in magenta, astressin
in yellow, and PACAP(6–38) in red.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2008,
283,
11340-11347)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.W.Day,
P.Li,
J.T.Patterson,
J.Chabenne,
M.D.Chabenne,
V.M.Gelfanov,
and
R.D.Dimarchi
(2011).
Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action.
|
| |
J Pept Sci,
17,
218-225.
|
 |
|
|
|
|
 |
N.Gong,
A.N.Ma,
L.J.Zhang,
X.S.Luo,
Y.H.Zhang,
M.Xu,
and
Y.X.Wang
(2011).
Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity.
|
| |
Br J Pharmacol,
163,
399-412.
|
 |
|
|
|
|
 |
C.R.Underwood,
P.Garibay,
L.B.Knudsen,
S.Hastrup,
G.H.Peters,
R.Rudolph,
and
S.Reedtz-Runge
(2010).
Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
|
| |
J Biol Chem,
285,
723-730.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.ter Haar,
C.M.Koth,
N.Abdul-Manan,
L.Swenson,
J.T.Coll,
J.A.Lippke,
C.A.Lepre,
M.Garcia-Guzman,
and
J.M.Moore
(2010).
Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
|
| |
Structure,
18,
1083-1093.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Nar,
A.Schmid,
C.Puder,
and
O.Potterat
(2010).
High-resolution crystal structure of a lasso Peptide.
|
| |
ChemMedChem,
5,
1689-1692.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Zettl,
M.Schubert-Zsilavecz,
and
D.Steinhilber
(2010).
Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors.
|
| |
ChemMedChem,
5,
179-185.
|
 |
|
|
|
|
 |
J.Gottfries,
and
L.Eriksson
(2010).
Extensions to amino acid description.
|
| |
Mol Divers,
14,
709-718.
|
 |
|
|
|
|
 |
J.P.Fortin,
J.C.Schroeder,
Y.Zhu,
M.Beinborn,
and
A.S.Kopin
(2010).
Pharmacological characterization of human incretin receptor missense variants.
|
| |
J Pharmacol Exp Ther,
332,
274-280.
|
 |
|
|
|
|
 |
M.Abraham-Nordling,
B.Persson,
and
E.Nordling
(2010).
Model of the complex of Parathyroid hormone-2 receptor and Tuberoinfundibular peptide of 39 residues.
|
| |
BMC Res Notes,
3,
270.
|
 |
|
|
|
|
 |
M.W.Wang,
Q.Liu,
and
C.H.Zhou
(2010).
Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery.
|
| |
Acta Pharmacol Sin,
31,
1026-1030.
|
 |
|
|
|
|
 |
P.S.Miller,
J.Barwell,
D.R.Poyner,
M.J.Wigglesworth,
S.L.Garland,
and
D.Donnelly
(2010).
Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.
|
| |
Biochem Biophys Res Commun,
391,
437-442.
|
 |
|
|
|
|
 |
T.Reiner,
R.H.Kohler,
C.W.Liew,
J.A.Hill,
J.Gaglia,
R.N.Kulkarni,
and
R.Weissleder
(2010).
Near-infrared fluorescent probe for imaging of pancreatic beta cells.
|
| |
Bioconjug Chem,
21,
1362-1368.
|
 |
|
|
|
|
 |
Y.Huang,
G.F.Wilkinson,
and
G.B.Willars
(2010).
Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.
|
| |
Br J Pharmacol,
159,
237-251.
|
 |
|
|
|
|
 |
A.A.Pioszak,
N.R.Parker,
T.J.Gardella,
and
H.E.Xu
(2009).
Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.
|
| |
J Biol Chem,
284,
28382-28391.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Parthier,
S.Reedtz-Runge,
R.Rudolph,
and
M.T.Stubbs
(2009).
Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
|
| |
Trends Biochem Sci,
34,
303-310.
|
 |
|
|
|
|
 |
C.Zhou,
D.Dhall,
N.N.Nissen,
C.R.Chen,
and
R.Yu
(2009).
Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
|
| |
Pancreas,
38,
941-946.
|
 |
|
|
|
|
 |
F.Lin,
and
R.Wang
(2009).
Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists.
|
| |
J Mol Model,
15,
53-65.
|
 |
|
|
|
|
 |
J.P.Fortin,
Y.Zhu,
C.Choi,
M.Beinborn,
M.N.Nitabach,
and
A.S.Kopin
(2009).
Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function.
|
| |
Proc Natl Acad Sci U S A,
106,
8049-8054.
|
 |
|
|
|
|
 |
J.W.Day,
N.Ottaway,
J.T.Patterson,
V.Gelfanov,
D.Smiley,
J.Gidda,
H.Findeisen,
D.Bruemmer,
D.J.Drucker,
N.Chaudhary,
J.Holland,
J.Hembree,
W.Abplanalp,
E.Grant,
J.Ruehl,
H.Wilson,
H.Kirchner,
S.H.Lockie,
S.Hofmann,
S.C.Woods,
R.Nogueiras,
P.T.Pfluger,
D.Perez-Tilve,
R.DiMarchi,
and
M.H.Tschöp
(2009).
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.
|
| |
Nat Chem Biol,
5,
749-757.
|
 |
|
|
|
|
 |
M.Dong,
and
L.J.Miller
(2009).
Effects of pH and temperature on photoaffinity labeling of Family B G protein-coupled receptors.
|
| |
Regul Pept,
158,
110-115.
|
 |
|
|
|
|
 |
Q.Chen,
D.I.Pinon,
L.J.Miller,
and
M.Dong
(2009).
Molecular basis of glucagon-like peptide 1 docking to its intact receptor studied with carboxyl-terminal photolabile probes.
|
| |
J Biol Chem,
284,
34135-34144.
|
 |
|
|
|
|
 |
R.L.McKown,
N.Wang,
R.W.Raab,
R.Karnati,
Y.Zhang,
P.B.Williams,
and
G.W.Laurie
(2009).
Lacritin and other new proteins of the lacrimal functional unit.
|
| |
Exp Eye Res,
88,
848-858.
|
 |
|
|
|
|
 |
A.A.Pioszak,
N.R.Parker,
K.Suino-Powell,
and
H.E.Xu
(2008).
Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1.
|
| |
J Biol Chem,
283,
32900-32912.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |